Bharat Biotech Seeks Approval of DCGI for Phase 3 Trials of Covid-19 Intranasal Vaccine
GG News Bureau
Hyderabad, 21st Dec. Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine, sources said on Monday.
Bharat Biotech has submitted…